I think the pressure will be mounting on Mark pretty soon. Cutting costs is the first thing you do but can only take you so far.
Profit from the turnover is just too low and they need to add new profitable contracts.
On current levels there is simply not enough left over to reinvest in the Company or to allow for any shocks or unforeseeable events.
Clyde
- Forums
- ASX - By Stock
- QHL
- Ann: Half Year FY21 Results
Ann: Half Year FY21 Results, page-10
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QHL (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.69M |
Open | High | Low | Value | Volume |
40.0¢ | 40.5¢ | 39.5¢ | $102.7K | 257.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 141207 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 2618 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 141207 | 0.395 |
1 | 60000 | 0.390 |
4 | 238250 | 0.385 |
1 | 39473 | 0.380 |
4 | 240000 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 2618 | 1 |
0.405 | 90320 | 4 |
0.410 | 170447 | 9 |
0.415 | 25641 | 1 |
0.420 | 30053 | 5 |
Last trade - 15.12pm 13/11/2024 (20 minute delay) ? |
Featured News
QHL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online